Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketoprofen patches vs Loxoprofen Sodium patches and placebo in knee osteoarthritis
CTR20234034Phase 3Completed
- Sponsor
- 九典制药
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ketoprofen in knee osteoarthritis (OA) (3 arms), sponsored by 九典制药. Primary endpoint: Change from baseline in VAS pain score (walking) at week 2. Started Dec 2023; status: completed.
02
Drugs
ketoprofen
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on CTR20234034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20234034.